Baicalin's Role in Controlling TH17 Cell Differentiation
Author Information
Author(s): Yang Ji, Yang Xue, Chu Yiwei, Li Ming
Primary Institution: Zhongshan Hospital, Fudan University, Shanghai, China
Hypothesis
Baicalin might inhibit inflammatory injuries by suppressing effector TH17 cells.
Conclusion
Baicalin can inhibit TH17 cell differentiation and may serve as a therapeutic agent for TH17-mediated inflammatory diseases.
Supporting Evidence
- Baicalin inhibited TH17 cell differentiation in vitro and in vivo.
- Treatment with Baicalin reduced TH17 cell infiltration into the kidneys of lupus-prone mice.
- Baicalin up-regulated Foxp3 expression while down-regulating RORγt-mediated IL-17 expression.
Takeaway
Baicalin is a natural compound that helps stop certain immune cells from causing inflammation, which can help treat diseases like lupus.
Methodology
The study involved in vitro and in vivo experiments using TH17 cell cultures and lupus-prone mice to assess the effects of Baicalin on TH17 differentiation.
Potential Biases
Potential bias may arise from the use of specific mouse models that may not fully represent human conditions.
Limitations
The study primarily focused on TH17 cells and did not explore the effects of Baicalin on other immune cell types in detail.
Participant Demographics
Lupus-prone MRL/lpr mice were used in the in vivo studies.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website